risk-adapted treatment in myelofibrosis: jak inhibitors and novel combination therapies
Published 3 years ago • 322 plays • Length 37:14Download video MP4
Download video MP3
Similar videos
-
1:03:11
management of myelofibrosis: jak inhibitors and novel therapeutics in the peri-transplant setting
-
1:20:00
understanding myelofibrosis: molecular biology, jak inhibitors, and emerging therapeutics
-
19:11
novel agents and combination therapies in myelofibrosis
-
1:34:09
jak inhibitors in myelofibrosis: expert insights on cases in personalizing therapy
-
2:04
novel therapies for myelofibrosis patients who have failed jak inhibitors
-
24:52
combination therapy with jak2 inhibitors in mpn
-
25:13
update on jak inhibitors for myelofibrosis: there is more than one
-
3:22
jak2 inhibition in the treatment of myelofibrosis
-
58:48
how to manage jak inhibition in patients undergoing hct
-
0:53
investigating the place of jak inhibitors in the treatment of myelofibrosis
-
25:15
how to manage side effects of jak inhibitors for mylofibrosis in the clinical practice
-
4:11
novel therapies and combinations for myelofibrosis patients
-
1:19
dr. srdan verstovsek on jak2 inhibitors as a treatment for myelofibrosis
-
14:05
myelofibrosis: emerging jak2 inhibitor combination treatment strategies
-
5:34
treating with a jak inhibitor for myelofibrosis
-
1:14
the application of jak inhibitors in the treatment of polycythemia vera and myelofibrosis
-
1:24
dr klisovic on the early use of jak inhibitors in younger patients with low-risk myelofibrosis
-
1:14
dr. mesa on the safety profiles of jak inhibitors in myelofibrosis
-
2:43
dr. tefferi on the outlook for jak inhibitors in myelofibrosis